25 XP   0   0   10

SenzaGen AB
Buy, Hold or Sell?

Let's analyse Senzagen together

PenkeI guess you are interested in SenzaGen AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SenzaGen AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about SenzaGen AB

I send you an email if I find something interesting about SenzaGen AB.

Quick analysis of Senzagen (30 sec.)










What can you expect buying and holding a share of Senzagen? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr2.80
Expected worth in 1 year
kr-0.86
How sure are you?
44.4%

+ What do you gain per year?

Total Gains per Share
kr-3.65
Return On Investment
-45.7%

For what price can you sell your share?

Current Price per Share
kr8.00
Expected price per share
kr5.92 - kr8
How sure are you?
50%

1. Valuation of Senzagen (5 min.)




Live pricePrice per Share (EOD)

kr8.00

Intrinsic Value Per Share

kr-5.73 - kr-0.21

Total Value Per Share

kr-2.93 - kr2.58

2. Growth of Senzagen (5 min.)




Is Senzagen growing?

Current yearPrevious yearGrowGrow %
How rich?$6.2m$8.2m-$2m-32.7%

How much money is Senzagen making?

Current yearPrevious yearGrowGrow %
Making money-$2m-$2.2m$259.2k12.7%
Net Profit Margin-44.3%-59.6%--

How much money comes from the company's main activities?

3. Financial Health of Senzagen (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#115 / 144

Most Revenue
#122 / 144

Most Profit
#72 / 144

What can you expect buying and holding a share of Senzagen? (5 min.)

Welcome investor! Senzagen's management wants to use your money to grow the business. In return you get a share of Senzagen.

What can you expect buying and holding a share of Senzagen?

First you should know what it really means to hold a share of Senzagen. And how you can make/lose money.

Speculation

The Price per Share of Senzagen is kr8. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Senzagen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Senzagen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr2.80. Based on the TTM, the Book Value Change Per Share is kr-0.91 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.85 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Senzagen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.08-1.1%-0.08-1.1%-0.09-1.2%-0.12-1.5%-0.08-1.0%
Usd Book Value Change Per Share-0.08-1.1%-0.08-1.1%-0.08-1.0%-0.01-0.2%0.030.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.08-1.1%-0.08-1.1%-0.08-1.0%-0.01-0.2%0.030.4%
Usd Price Per Share0.67-0.67-1.11-1.13-1.31-
Price to Earnings Ratio-7.97--7.97--11.70--9.61--17.79-
Price-to-Total Gains Ratio-7.97--7.97--14.19-14.78-4.83-
Price to Book Ratio2.60-2.60-3.25-2.87-3.51-
Price-to-Total Gains Ratio-7.97--7.97--14.19-14.78-4.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.7368
Number of shares1357
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.08-0.01
Usd Total Gains Per Share-0.08-0.01
Gains per Quarter (1357 shares)-114.15-18.94
Gains per Year (1357 shares)-456.61-75.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-457-4670-76-86
20-913-9240-152-162
30-1370-13810-227-238
40-1826-18380-303-314
50-2283-22950-379-390
60-2740-27520-455-466
70-3196-32090-530-542
80-3653-36660-606-618
90-4110-41230-682-694
100-4566-45800-758-770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.05.00.044.4%4.05.00.044.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.05.00.044.4%4.05.00.044.4%

Fundamentals of Senzagen

About SenzaGen AB

SenzaGen AB provides non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative skin sensitizing potency assessment of chemicals; and GARDair, an in vitro test for identifying chemical respiratory sensitizers, as well as GARDskin medical device, an in vitro skin sensitization testing for medical devices and solid materials. It also provides irritation, corrosion, sensitization, and absorption testing services, as well as phototoxicity services. The company offers services through license partners and distributors. It has a collaboration agreement with the Research Institute for Fragrance Materials to develop tests for photosensitization. The company was incorporated in 2010 and is headquartered in Lund, Sweden.

Fundamental data was last updated by Penke on 2024-04-25 02:29:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of SenzaGen AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Senzagen earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Senzagen to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -44.3% means that kr-0.44 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SenzaGen AB:

  • The MRQ is -44.3%. The company is making a huge loss. -2
  • The TTM is -44.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-44.3%TTM-44.3%0.0%
TTM-44.3%YOY-59.6%+15.3%
TTM-44.3%5Y-498.9%+454.6%
5Y-498.9%10Y-709.6%+210.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-44.3%-7.3%-37.0%
TTM-44.3%-6.7%-37.6%
YOY-59.6%-1.9%-57.7%
5Y-498.9%-1.5%-497.4%
10Y-709.6%-3.4%-706.2%
1.1.2. Return on Assets

Shows how efficient Senzagen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Senzagen to the Diagnostics & Research industry mean.
  • -22.7% Return on Assets means that Senzagen generated kr-0.23 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SenzaGen AB:

  • The MRQ is -22.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -22.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.7%TTM-22.7%0.0%
TTM-22.7%YOY-20.8%-2.0%
TTM-22.7%5Y-25.3%+2.6%
5Y-25.3%10Y-20.9%-4.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.7%-1.6%-21.1%
TTM-22.7%-1.3%-21.4%
YOY-20.8%-0.9%-19.9%
5Y-25.3%-0.5%-24.8%
10Y-20.9%-0.9%-20.0%
1.1.3. Return on Equity

Shows how efficient Senzagen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Senzagen to the Diagnostics & Research industry mean.
  • -32.7% Return on Equity means Senzagen generated kr-0.33 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SenzaGen AB:

  • The MRQ is -32.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -32.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-32.7%TTM-32.7%0.0%
TTM-32.7%YOY-27.8%-4.9%
TTM-32.7%5Y-30.3%-2.4%
5Y-30.3%10Y-24.2%-6.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-32.7%-0.5%-32.2%
TTM-32.7%0.2%-32.9%
YOY-27.8%-0.3%-27.5%
5Y-30.3%-1.4%-28.9%
10Y-24.2%-2.3%-21.9%

1.2. Operating Efficiency of SenzaGen AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Senzagen is operating .

  • Measures how much profit Senzagen makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Senzagen to the Diagnostics & Research industry mean.
  • An Operating Margin of -29.6% means the company generated kr-0.30  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SenzaGen AB:

  • The MRQ is -29.6%. The company is operating very inefficient. -2
  • The TTM is -29.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-29.6%TTM-29.6%0.0%
TTM-29.6%YOY-48.3%+18.8%
TTM-29.6%5Y-403.0%+373.5%
5Y-403.0%10Y-666.1%+263.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.6%-8.8%-20.8%
TTM-29.6%0.5%-30.1%
YOY-48.3%4.0%-52.3%
5Y-403.0%3.7%-406.7%
10Y-666.1%-1.3%-664.8%
1.2.2. Operating Ratio

Measures how efficient Senzagen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.30 means that the operating costs are kr1.30 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of SenzaGen AB:

  • The MRQ is 1.296. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.296. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.296TTM1.2960.000
TTM1.296YOY1.483-0.188
TTM1.2965Y5.030-3.735
5Y5.03010Y8.832-3.802
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2961.280+0.016
TTM1.2961.304-0.008
YOY1.4831.240+0.243
5Y5.0301.242+3.788
10Y8.8321.205+7.627

1.3. Liquidity of SenzaGen AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Senzagen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.45 means the company has kr1.45 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of SenzaGen AB:

  • The MRQ is 1.447. The company is just able to pay all its short-term debts.
  • The TTM is 1.447. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.447TTM1.4470.000
TTM1.447YOY1.984-0.537
TTM1.4475Y10.779-9.332
5Y10.77910Y11.829-1.050
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4472.111-0.664
TTM1.4472.298-0.851
YOY1.9842.599-0.615
5Y10.7793.012+7.767
10Y11.8293.081+8.748
1.3.2. Quick Ratio

Measures if Senzagen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Senzagen to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.16 means the company can pay off kr1.16 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SenzaGen AB:

  • The MRQ is 1.158. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.158. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.158TTM1.1580.000
TTM1.158YOY1.803-0.645
TTM1.1585Y10.520-9.362
5Y10.52010Y11.502-0.982
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1581.230-0.072
TTM1.1581.345-0.187
YOY1.8031.661+0.142
5Y10.5201.957+8.563
10Y11.5022.295+9.207

1.4. Solvency of SenzaGen AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Senzagen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Senzagen to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.30 means that Senzagen assets are financed with 30.4% credit (debt) and the remaining percentage (100% - 30.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SenzaGen AB:

  • The MRQ is 0.304. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.304. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.304TTM0.3040.000
TTM0.304YOY0.252+0.052
TTM0.3045Y0.165+0.139
5Y0.16510Y0.122+0.044
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3040.432-0.128
TTM0.3040.407-0.103
YOY0.2520.394-0.142
5Y0.1650.448-0.283
10Y0.1220.446-0.324
1.4.2. Debt to Equity Ratio

Measures if Senzagen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Senzagen to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 43.7% means that company has kr0.44 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SenzaGen AB:

  • The MRQ is 0.437. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.437. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.437TTM0.4370.000
TTM0.437YOY0.337+0.100
TTM0.4375Y0.218+0.220
5Y0.21810Y0.153+0.065
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4370.606-0.169
TTM0.4370.571-0.134
YOY0.3370.603-0.266
5Y0.2180.651-0.433
10Y0.1530.739-0.586

2. Market Valuation of SenzaGen AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Senzagen generates.

  • Above 15 is considered overpriced but always compare Senzagen to the Diagnostics & Research industry mean.
  • A PE ratio of -7.97 means the investor is paying kr-7.97 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SenzaGen AB:

  • The EOD is -8.757. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.969. Based on the earnings, the company is expensive. -2
  • The TTM is -7.969. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.757MRQ-7.969-0.788
MRQ-7.969TTM-7.9690.000
TTM-7.969YOY-11.700+3.731
TTM-7.9695Y-9.607+1.638
5Y-9.60710Y-17.795+8.188
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-8.757-0.259-8.498
MRQ-7.969-0.395-7.574
TTM-7.969-0.199-7.770
YOY-11.700-0.008-11.692
5Y-9.6073.483-13.090
10Y-17.7954.434-22.229
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SenzaGen AB:

  • The EOD is -9.551. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.691. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.691. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.551MRQ-8.691-0.860
MRQ-8.691TTM-8.6910.000
TTM-8.691YOY-15.620+6.929
TTM-8.6915Y-11.502+2.811
5Y-11.50210Y-13.906+2.404
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-9.551-0.405-9.146
MRQ-8.691-0.561-8.130
TTM-8.691-1.388-7.303
YOY-15.620-2.175-13.445
5Y-11.502-1.249-10.253
10Y-13.906-1.895-12.011
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Senzagen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.60 means the investor is paying kr2.60 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of SenzaGen AB:

  • The EOD is 2.862. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.605. Based on the equity, the company is underpriced. +1
  • The TTM is 2.605. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.862MRQ2.605+0.258
MRQ2.605TTM2.6050.000
TTM2.605YOY3.249-0.645
TTM2.6055Y2.870-0.266
5Y2.87010Y3.515-0.645
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.8622.018+0.844
MRQ2.6052.211+0.394
TTM2.6052.168+0.437
YOY3.2493.014+0.235
5Y2.8703.475-0.605
10Y3.5154.079-0.564
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of SenzaGen AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.913-0.9130%-0.849-7%-0.152-83%0.311-394%
Book Value Per Share--2.7952.7950%3.708-25%4.213-34%3.541-21%
Current Ratio--1.4471.4470%1.984-27%10.779-87%11.829-88%
Debt To Asset Ratio--0.3040.3040%0.252+21%0.165+84%0.122+150%
Debt To Equity Ratio--0.4370.4370%0.337+30%0.218+101%0.153+186%
Dividend Per Share----0%-0%-0%-0%
Eps---0.914-0.9140%-1.030+13%-1.288+41%-0.903-1%
Free Cash Flow Per Share---0.838-0.8380%-0.771-8%-1.067+27%-0.895+7%
Free Cash Flow To Equity Per Share---0.832-0.8320%-0.770-7%-0.020-98%0.267-411%
Gross Profit Margin--2.2122.2120%1.867+18%1.770+25%1.428+55%
Intrinsic Value_10Y_max---0.211--------
Intrinsic Value_10Y_min---5.728--------
Intrinsic Value_1Y_max---0.682--------
Intrinsic Value_1Y_min---0.953--------
Intrinsic Value_3Y_max---1.546--------
Intrinsic Value_3Y_min---2.551--------
Intrinsic Value_5Y_max---1.803--------
Intrinsic Value_5Y_min---3.797--------
Market Cap193506400.000+9%176090824.000176090824.0000%291469015.000-40%295532649.400-40%342855714.556-49%
Net Profit Margin---0.443-0.4430%-0.596+35%-4.989+1026%-7.096+1501%
Operating Margin---0.296-0.2960%-0.483+64%-4.030+1264%-6.661+2154%
Operating Ratio--1.2961.2960%1.483-13%5.030-74%8.832-85%
Pb Ratio2.862+9%2.6052.6050%3.249-20%2.870-9%3.515-26%
Pe Ratio-8.757-10%-7.969-7.9690%-11.700+47%-9.607+21%-17.795+123%
Price Per Share8.000+9%7.2807.2800%12.050-40%12.218-40%14.174-49%
Price To Free Cash Flow Ratio-9.551-10%-8.691-8.6910%-15.620+80%-11.502+32%-13.906+60%
Price To Total Gains Ratio-8.759-10%-7.970-7.9700%-14.189+78%14.777-154%4.829-265%
Quick Ratio--1.1581.1580%1.803-36%10.520-89%11.502-90%
Return On Assets---0.227-0.2270%-0.208-9%-0.253+11%-0.209-8%
Return On Equity---0.327-0.3270%-0.278-15%-0.303-7%-0.242-26%
Total Gains Per Share---0.913-0.9130%-0.849-7%-0.152-83%0.311-394%
Usd Book Value--6226696.8006226696.8000%8261462.100-25%9386003.100-34%7888047.767-21%
Usd Book Value Change Per Share---0.084-0.0840%-0.078-7%-0.014-83%0.029-394%
Usd Book Value Per Share--0.2570.2570%0.342-25%0.388-34%0.326-21%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.084-0.0840%-0.095+13%-0.119+41%-0.083-1%
Usd Free Cash Flow---1866038.100-1866038.1000%-1718586.000-8%-2377653.600+27%-1994435.733+7%
Usd Free Cash Flow Per Share---0.077-0.0770%-0.071-8%-0.098+27%-0.082+7%
Usd Free Cash Flow To Equity Per Share---0.077-0.0770%-0.071-7%-0.002-98%0.025-411%
Usd Market Cap17821939.440+9%16217964.89016217964.8900%26844296.282-40%27218557.010-40%31577011.311-49%
Usd Price Per Share0.737+9%0.6700.6700%1.110-40%1.125-40%1.305-49%
Usd Profit---2035133.700-2035133.7000%-2294395.200+13%-2871806.940+41%-2013817.667-1%
Usd Revenue--4593027.0004593027.0000%3847017.000+19%2168844.480+112%1260132.667+264%
Usd Total Gains Per Share---0.084-0.0840%-0.078-7%-0.014-83%0.029-394%
 EOD+5 -3MRQTTM+0 -0YOY+11 -235Y+14 -2010Y+10 -24

3.2. Fundamental Score

Let's check the fundamental score of SenzaGen AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.757
Price to Book Ratio (EOD)Between0-12.862
Net Profit Margin (MRQ)Greater than0-0.443
Operating Margin (MRQ)Greater than0-0.296
Quick Ratio (MRQ)Greater than11.158
Current Ratio (MRQ)Greater than11.447
Debt to Asset Ratio (MRQ)Less than10.304
Debt to Equity Ratio (MRQ)Less than10.437
Return on Equity (MRQ)Greater than0.15-0.327
Return on Assets (MRQ)Greater than0.05-0.227
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of SenzaGen AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.125
Ma 20Greater thanMa 506.631
Ma 50Greater thanMa 1006.444
Ma 100Greater thanMa 2006.685
OpenGreater thanClose7.160
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets97,176
Total Liabilities29,568
Total Stockholder Equity67,608
 As reported
Total Liabilities 29,568
Total Stockholder Equity+ 67,608
Total Assets = 97,176

Assets

Total Assets97,176
Total Current Assets40,355
Long-term Assets56,821
Total Current Assets
Cash And Cash Equivalents 17,624
Net Receivables 14,686
Inventory 6,228
Other Current Assets 1,817
Total Current Assets  (as reported)40,355
Total Current Assets  (calculated)40,355
+/-0
Long-term Assets
Property Plant Equipment 1,811
Goodwill 20,993
Intangible Assets 34,017
Long-term Assets  (as reported)56,821
Long-term Assets  (calculated)56,821
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities27,895
Long-term Liabilities1,673
Total Stockholder Equity67,608
Total Current Liabilities
Short-term Debt 421
Accounts payable 5,691
Other Current Liabilities 21,416
Total Current Liabilities  (as reported)27,895
Total Current Liabilities  (calculated)27,528
+/- 367
Long-term Liabilities
Long term Debt 1,673
Long-term Liabilities  (as reported)1,673
Long-term Liabilities  (calculated)1,673
+/-0
Total Stockholder Equity
Common Stock1,209
Retained Earnings 62,624
Accumulated Other Comprehensive Income 3,720
Other Stockholders Equity 55
Total Stockholder Equity (as reported)67,608
Total Stockholder Equity (calculated)67,608
+/-0
Other
Capital Stock1,209
Cash and Short Term Investments 17,624
Common Stock Shares Outstanding 24,188
Current Deferred Revenue367
Liabilities and Stockholders Equity 97,176
Net Debt -15,951
Net Invested Capital 69,281
Net Working Capital 12,460
Property Plant and Equipment Gross 15,177
Short Long Term Debt Total 1,673



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
45,351
34,922
108,675
90,469
142,960
111,548
133,805
119,954
97,176
97,176119,954133,805111,548142,96090,469108,67534,92245,351
   > Total Current Assets 
40,175
23,350
84,597
59,230
123,608
94,084
81,405
57,625
40,355
40,35557,62581,40594,084123,60859,23084,59723,35040,175
       Cash And Cash Equivalents 
37,944
22,578
82,732
56,632
120,467
89,343
69,164
39,976
17,624
17,62439,97669,16489,343120,46756,63282,73222,57837,944
       Net Receivables 
0
766
105
700
1,979
3,143
7,839
12,400
14,686
14,68612,4007,8393,1431,9797001057660
       Other Current Assets 
2,231
772
1,865
2,598
458
533
1,201
1,635
1,817
1,8171,6351,2015334582,5981,8657722,231
   > Long-term Assets 
5,176
11,572
24,078
31,239
19,352
17,464
52,400
62,329
56,821
56,82162,32952,40017,46419,35231,23924,07811,5725,176
       Property Plant Equipment 
126
1,173
4,320
3,723
3,273
2,097
3,230
2,575
1,811
1,8112,5753,2302,0973,2733,7234,3201,173126
       Goodwill 
0
0
0
0
0
0
13,109
21,647
20,993
20,99321,64713,109000000
       Intangible Assets 
0
5,931
11,743
15,022
16,079
15,367
36,061
38,107
34,017
34,01738,10736,06115,36716,07915,02211,7435,9310
       Long-term Assets Other 
3,067
5,969
-11,743
0
0
0
0
0
34,017
34,01700000-11,7435,9693,067
> Total Liabilities 
3,744
2,211
7,665
4,533
8,749
3,756
23,562
30,253
29,568
29,56830,25323,5623,7568,7494,5337,6652,2113,744
   > Total Current Liabilities 
2,244
2,211
7,665
4,533
5,657
3,756
22,848
29,046
27,895
27,89529,04622,8483,7565,6574,5337,6652,2112,244
       Short-term Debt 
0
0
0
0
0
0
-1,546
-99
421
421-99-1,546000000
       Accounts payable 
840
1,186
4,058
963
2,843
1,306
3,135
4,420
5,691
5,6914,4203,1351,3062,8439634,0581,186840
       Other Current Liabilities 
1,404
1,025
3,607
3,570
2,814
2,450
19,713
24,626
21,416
21,41624,62619,7132,4502,8143,5703,6071,0251,404
   > Long-term Liabilities 
1,500
0
0
0
3,092
1,306
714
1,207
1,673
1,6731,2077141,3063,0920001,500
       Long term Debt Total 
0
0
0
0
0
0
714
1,207
0
01,207714000000
       Other Liabilities 
0
0
0
0
3,092
1,286
15,791
0
0
0015,7911,2863,0920000
       Deferred Long Term Liability 
0
4,369
7,944
9,684
9,376
7,158
10,631
7,759
0
07,75910,6317,1589,3769,6847,9444,3690
> Total Stockholder Equity
41,607
32,711
101,010
85,936
134,211
107,792
110,243
89,701
67,608
67,60889,701110,243107,792134,21185,936101,01032,71141,607
   Common Stock
108
108
773
779
1,068
1,068
1,203
1,209
1,209
1,2091,2091,2031,0681,068779773108108
   Retained Earnings 
-1,002
-9,952
-23,444
-40,969
27,430
100,902
105,607
83,985
62,624
62,62483,985105,607100,90227,430-40,969-23,444-9,952-1,002
   Capital Surplus 
0
42,555
80,870
2,445
105,713
698
2,739
921
0
09212,739698105,7132,44580,87042,5550
   Treasury Stock000000000
   Other Stockholders Equity 
42,501
42,555
123,681
126,126
105,713
5,822
2,739
921
55
559212,7395,822105,713126,126123,68142,55542,501



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue49,870
Cost of Revenue-14,938
Gross Profit34,93234,932
 
Operating Income (+$)
Gross Profit34,932
Operating Expense-49,672
Operating Income-14,740-14,740
 
Operating Expense (+$)
Research Development3,747
Selling General Administrative19,138
Selling And Marketing Expenses26,787
Operating Expense49,67249,672
 
Net Interest Income (+$)
Interest Income564
Interest Expense-37
Other Finance Cost-17
Net Interest Income510
 
Pretax Income (+$)
Operating Income-14,740
Net Interest Income510
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-21,976-7,504
EBIT - interestExpense = -14,777
-21,976
-22,060
Interest Expense37
Earnings Before Interest and Taxes (EBIT)-14,740-21,939
Earnings Before Interest and Taxes (EBITDA)-6,554
 
After tax Income (+$)
Income Before Tax-21,976
Tax Provision-121
Net Income From Continuing Ops-22,097-22,097
Net Income-22,097
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses64,610
Total Other Income/Expenses Net-7,236-510
 

Technical Analysis of Senzagen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Senzagen. The general trend of Senzagen is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Senzagen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SenzaGen AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 7.78 < 7.86 < 8.

The bearish price targets are: 6 > 6 > 5.92.

Tweet this
SenzaGen AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SenzaGen AB. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SenzaGen AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SenzaGen AB. The current macd is 0.22742307.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Senzagen price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Senzagen. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Senzagen price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
SenzaGen AB Daily Moving Average Convergence/Divergence (MACD) ChartSenzaGen AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SenzaGen AB. The current adx is 32.27.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Senzagen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
SenzaGen AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SenzaGen AB. The current sar is 5.9556.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
SenzaGen AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SenzaGen AB. The current rsi is 68.12. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
SenzaGen AB Daily Relative Strength Index (RSI) ChartSenzaGen AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SenzaGen AB. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Senzagen price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
SenzaGen AB Daily Stochastic Oscillator ChartSenzaGen AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SenzaGen AB. The current cci is 187.51.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
SenzaGen AB Daily Commodity Channel Index (CCI) ChartSenzaGen AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SenzaGen AB. The current cmo is 51.11.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
SenzaGen AB Daily Chande Momentum Oscillator (CMO) ChartSenzaGen AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SenzaGen AB. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
SenzaGen AB Daily Williams %R ChartSenzaGen AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SenzaGen AB.

SenzaGen AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SenzaGen AB. The current atr is 0.46798215.

SenzaGen AB Daily Average True Range (ATR) ChartSenzaGen AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SenzaGen AB. The current obv is -1,050,206.

SenzaGen AB Daily On-Balance Volume (OBV) ChartSenzaGen AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SenzaGen AB. The current mfi is 60.69.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
SenzaGen AB Daily Money Flow Index (MFI) ChartSenzaGen AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SenzaGen AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

SenzaGen AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SenzaGen AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.125
Ma 20Greater thanMa 506.631
Ma 50Greater thanMa 1006.444
Ma 100Greater thanMa 2006.685
OpenGreater thanClose7.160
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Senzagen with someone you think should read this too:
  • Are you bullish or bearish on Senzagen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Senzagen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SenzaGen AB

I send you an email if I find something interesting about SenzaGen AB.


Comments

How you think about this?

Leave a comment

Stay informed about SenzaGen AB.

Receive notifications about SenzaGen AB in your mailbox!